Failure of Technical Communication in Remote Monitoring of
Cardiac Implantable Electronic Devices
Results of a Long-term Study
Pedro Silva Cunha, Mário Martins Oliveira, Manuel Nogueira da Silva, Joana Feliciano,
Sandra Alves, Ricardo Pimenta, Sofia Almeida Santos and Rui Cruz Ferreira
Santa Marta Hospital, Cardiology Service, Rua de Santa Marta nº 50, 1169-024 Lisboa, Portugal
Keywords: Remote Monitoring, Cardiac Implantable Electronic Devices.
Abstract: Remote monitoring of cardiac implantable electronic devices has been developed for technical control and
follow-up using transtelephonic data transmission methods. In this study we explore the pitfalls of a remote
monitoring program concerning failure of data transmission in a population with implantable cardioverter-
defibrillators.
1 INTRODUCTION
Remote monitoring of cardiac implantable electronic
devices has been developed for technical control and
follow-up using transtelephonic data transmission
methods. This technology allows evaluation of
settings and status of cardiac implantable electronic
devices and the resulting outcome. The remote
monitoring features transmit selected device-related
data to a service-center via a standard phone line or
a mobile phone network. In case of a potential
emergency situation, event reports are generated
automatically according to the selected setting for
alarms notification. It has been proven to be
technically reliable, allowing early identification of
device malfunction and arrhythmic events, and
minimizing the risk of under-reporting. This remote
interrogation can be used for scheduled and
unscheduled technical and patient monitoring and
follow-up. However, there is lack of data regarding
technical problems related with failure of
communication and data transmission.
2 AIM
To explore the pitfalls of a long-term remote
monitoring program regarding data transmission in a
population with an implantable cardioverter-
defibrillator (ICD).
3 METHODS
We reviewed the data from two hundred and sixty
patients (74% men; 60.4±14.6 years) with an ICD
(n=190; 21% dual-chamber) or an ICD combined
with a cardiac resynchronization therapy device
(n=70).
Cardiac implantable electronic devices were
implanted for primary prevention of sudden death in
160 cases and for secondary prevention in 100 cases.
The cardiac implantable electronic devices and
remote monitoring systems manufacturer´s were
Biotronik (n=95), Medtronic (n=92); Boston
Scientific (n=62) and Sorin (n=8).
Data was incorporated into the hospital
information system via web and analyzed by an
allied professional and an electrophysiologist in a
single center follow-up program. The transmitter
will only send the data according to scheduled time
intervals or if requested by the patient or health-care
professional (non-scheduled transmission). Patients
were included in the study if they were followed-up
for a period longer than 6 months. We considered
data of all transmissions, including communication
concerning cardiac implantable electronic devices
and the transmitter, communication amongst the
transmitter and the manufacturer’s remote
monitoring data centre, and communication between
the manufacturer’s data centre and the hospital. The
data could be sent to the manufacturer’s remote
monitoring data centre by the conventional
Silva Cunha P., Martins Oliveira M., Nogueira da Silva M., Feliciano J., Alves S., Pimenta R., Almeida Santos S. and Ferreira R..
Failure of Technical Communication in Remote Monitoring of Cardiac Implantable Electronic Devices - Results of a Long-term Study.
Copyright
c
2013 SCITEPRESS (Science and Technology Publications, Lda.)
telephone cable network often called a ‘landline’ or
by a digital cellular phone technology. All
communication between the transmitter and the
manufacturer’s data centre were encrypted to
guarantee patient privacy and safety.
4 RESULTS
After a mean follow-up of 34±18 months, there were
alert messages in 60 patients (range from 1 to 234
per patient) resulting in a response from the health-
care team (<48 hours period of time).
In the majority of cases (83%) the information
was due to ventricular tachyarrhythmia (n=24) or
atrial fibrillation (n=26) episodes. Failure of data
transmission occurred in 9 patients (3,4%),
distributed by all device companies, and were due
to: reduced signal strength of landline phone in the
coverage area (n=2), repeated local energy failure
(n=1), travelling abroad (n=2), technical problems
with the transmitter (n=3), unknown (n=1).
After identification of the type of difficulty the
transmission problems were solved after new
instructions for the management of the transmitter or
changing of the communication equipment in 3 of
the cases.
5 CONCLUSIONS
Remote monitoring systems may represent an
advantage in the complex follow-up of cardiac
implantable electronic devices. However, in a long-
term period, there are a few cases in which data
transmission failed due to technical communication
problems.
REFERENCES
Morichelli L., Ricci R. P.: Remote monitoring of
implantable devices: the European experience. Heart
Rhythm. 2009;6(7):1077–80).
Maisel W. H., Kohno T. Improving the security and
privacy of implantable medical devices. N Engl J
Med. 2010;362(13):1164–1166).
Dubner, S. et al., 2012. ISHNE/EHRA expert consensus
on remote monitoring of cardiovascular implantable
electronic devices (CIEDs). Europace, 14(2), pp.278-
293.